Literature DB >> 25983935

Acute renal failure and multiple sites of ischaemia: what is the unifying diagnosis?

Kirsty Le Doaré1, Seyed Ameli-Renani1, Debasish Banerjee1, Stephen J D Brecker1, John B Eastwood1.   

Abstract

Entities:  

Keywords:  acute renal failure; patent foramen ovale; renal artery embolism

Year:  2008        PMID: 25983935      PMCID: PMC4421274          DOI: 10.1093/ndtplus/sfn104

Source DB:  PubMed          Journal:  NDT Plus        ISSN: 1753-0784


× No keyword cloud information.
A 67-year-old man presented to the Accident and Emergency department in September 2004 with cough and sudden shortness of breath. In 2002, he had suffered a left occipital infarct that presented as a transient ischaemic attack. In 2003, he sustained bilateral cerebellar infarcts that left him with residual tremor and ataxia (Figure 1). He took regular aspirin, clopidogrel and simvastatin for secondary prevention of cerebrovascular events.
Fig. 1

Diffusion weighted MRI of head, 2003.

Diffusion weighted MRI of head, 2003. On presentation his oxygen saturation was 79%, heart rate 120/min, respiratory rate 40/min and blood pressure 155/112 mm Hg. Chest auscultation revealed crackles and decreased air entry at the left base. Examination of the heart and abdomen was normal. He had type 1 respiratory failure (pO2 6.1 kPa, pCO2 4.5 kPa). Full blood count, creatinine (75 μmol/l), electrolytes and clotting were normal. A chest radiograph showed left basal shadowing and prominent hila. He was treated with heparin and aspirin for suspected pulmonary embolism; CT pulmonary angiography was performed (Figure 2).
Fig. 2

CT pulmonary angiogram.

CT pulmonary angiogram. Two days later he developed nausea, vomiting and a sudden sharp constant pain in the left flank passing into the iliac fossa, not relieved by morphine. Abdominally, he was tender in the left hypochondrium and iliac fossa. There were no urinary symptoms. Concurrently, there was an abrupt rise of urea to 16.6 mmol/l and creatinine to 450 μmol/l. He underwent abdominal CT scan and echocardiography (Figures 3, 4).
Fig. 3

CT of abdomen.

Fig. 4

Transthoracic contrast echocardiogram.

CT of abdomen. Transthoracic contrast echocardiogram.

Question

What is the unifying diagnosis?

Answers to the quiz

Figure 1: Old right cerebellar infarct shown as a region of hypointensity and new left cerebellar infarct shown as a region of hyperintensity. Figure 2: Multiple large pulmonary emboli. Figure 3: Complete infarct of left kidney and wedge infarct of right kidney. Figure 4: Transthoracic contrast echocardiogram de- monstrating atrial septal aneurysm and patent foramen ovale.

Clinical diagnosis

Paradoxical embolism, i.e. systemic embolism via patent foramen ovale (PFO).

Comment

The foramen ovale is patent in 27–35% of adults [1]. Such patency presents an opportunity for systemic venous thrombi to find their way into the systemic arterial circulation, and cause embolic phenomena including stroke, myocardial infarction and peripheral arterial occlusion. Therefore, in any patient presenting with an unexplained thromobembolic event, it is important to consider PFO. PFO can be managed in one of two ways: medical treatment (antiplatelet or anticoagulation) or percutaneous catheter closure. Open surgical closure is now rarely, if ever, necessary. A number of studies, in patients with thromboembolic events complicating PFO, have shown the benefits of anticoagulation. By using aspirin and/or warfarin, the stroke recurrence rate can be as low as 1.9% (95% CI; 1.48–2.60) [2]; 5-year survival rates are >90% [3]. In practice, percutaneous closure by catheter is now the standard management in adults whose PFO has produced symptoms [4]. The procedure, however, is not without complications—air embolism, perforation and pericardial effusion, residual shunt and failure/embolisation of the device itself. There is evidence that in experienced hands complications are now very few [5]. In the patient described above, closure [deployment of a 25 mm right atrial disc sized Amplazter (GA Medical Institute, GA, USA) PFO occluder] was carried out in November 2005 under general anaesthesia using trans-oesophageal echocardiographic guidance. Heparin and antibiotics were given. After the procedure, echocardiography was most satisfactory and showed no residual shunt. Alternatively, the procedure could have been carried out under local anaesthetic using intracardiac echocardiography or even fluoroscopy alone. When last seen in February 2008, the patient was well with stable creatinine (143 μmol/l).
  5 in total

Review 1.  Patent foramen ovale and stroke.

Authors:  Shunichi Homma; Ralph L Sacco
Journal:  Circulation       Date:  2005-08-16       Impact factor: 29.690

2.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

Authors:  P T Hagen; D G Scholz; W D Edwards
Journal:  Mayo Clin Proc       Date:  1984-01       Impact factor: 7.616

3.  Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.

Authors:  Basil Vasilios D Thanopoulos; Petros D Dardas; Evangelos Karanasios; Nicholaos Mezilis
Journal:  Catheter Cardiovasc Interv       Date:  2006-11       Impact factor: 2.692

4.  Closure of defects of the atrial septum in adults using the Amplatzer device: 100 consecutive patients in a single center.

Authors:  I F Purcell; S J Brecker; D E Ward
Journal:  Clin Cardiol       Date:  2004-09       Impact factor: 2.882

5.  A comparison of surgical and medical therapy for atrial septal defect in adults.

Authors:  S Konstantinides; A Geibel; M Olschewski; L Görnandt; H Roskamm; G Spillner; H Just; W Kasper
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.